A double blind randomised placebo-controlled trial of amoxycillin and budesonide in patients with acute rhinosinusitis in general practice

Completed

• Conditions: Ear, nose and throat diseases: Ear, nose and throat diseases; Ear, Nose and Throat; Acute rhinosinusitis

• Registration Number: ISRCTN84277311
• Lead Sponsor: HS R&D Regional Programme Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 240

Inclusion Criteria

Patients 16 years or over attending the GP for acute rhinosinusitis, who agree to be randomised.

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The percentage with diary recorded complete resolution of all symptoms (cured) at 14 days.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration